does semaglutide affect kidneys Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Semaglutide cuts kidney risk in

Finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, is recommended at a daily dose of 20 mg for patients with eGFR 60 mL/min/1.73 m and 10 mg for those with eGFR between 25 and 60 mL/min/1.73 m

But for now, most gut benefits on GLP-1s seem driven by reduced energy intake, improved glycemic control, and weight loss, not a consistent, reproducible microbiome signature

For many people, yes but it depends on your liver health and medications

If you have a non-standard vial size or different BAC water volume, use the free PepPal calculator to get the exact draw volume and syringe units

GHRH-GHSR Synergy Bowers et al